These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
654 related articles for article (PubMed ID: 18457818)
1. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Rezai-Zadeh K; Arendash GW; Hou H; Fernandez F; Jensen M; Runfeldt M; Shytle RD; Tan J Brain Res; 2008 Jun; 1214():177-87. PubMed ID: 18457818 [TBL] [Abstract][Full Text] [Related]
2. Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice. Arendash GW; Mori T; Cao C; Mamcarz M; Runfeldt M; Dickson A; Rezai-Zadeh K; Tane J; Citron BA; Lin X; Echeverria V; Potter H J Alzheimers Dis; 2009; 17(3):661-80. PubMed ID: 19581722 [TBL] [Abstract][Full Text] [Related]
3. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338 [TBL] [Abstract][Full Text] [Related]
4. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production. Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404 [TBL] [Abstract][Full Text] [Related]
5. Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice. Pan X; Gong N; Zhao J; Yu Z; Gu F; Chen J; Sun X; Zhao L; Yu M; Xu Z; Dong W; Qin Y; Fei G; Zhong C; Xu TL Brain; 2010 May; 133(Pt 5):1342-51. PubMed ID: 20385653 [TBL] [Abstract][Full Text] [Related]
6. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment. Leon WC; Canneva F; Partridge V; Allard S; Ferretti MT; DeWilde A; Vercauteren F; Atifeh R; Ducatenzeiler A; Klein W; Szyf M; Alhonen L; Cuello AC J Alzheimers Dis; 2010; 20(1):113-26. PubMed ID: 20164597 [TBL] [Abstract][Full Text] [Related]
7. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice. Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404 [TBL] [Abstract][Full Text] [Related]
8. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747 [TBL] [Abstract][Full Text] [Related]
9. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein. Lee KW; Lee SH; Kim H; Song JS; Yang SD; Paik SG; Han PL J Neurosci Res; 2004 May; 76(4):572-80. PubMed ID: 15114629 [TBL] [Abstract][Full Text] [Related]
10. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau. Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643 [TBL] [Abstract][Full Text] [Related]
11. Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: linkage of poorer cognitive performance to tau pathology in forebrain. Arendash GW; Lewis J; Leighty RE; McGowan E; Cracchiolo JR; Hutton M; Garcia MF Brain Res; 2004 Jun; 1012(1-2):29-41. PubMed ID: 15158158 [TBL] [Abstract][Full Text] [Related]
12. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice. Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756 [TBL] [Abstract][Full Text] [Related]
13. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern. Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269 [TBL] [Abstract][Full Text] [Related]
14. Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment. Hedberg MM; Svedberg MM; Mustafiz T; Yu WF; Mousavi M; Guan ZZ; Unger C; Nordberg A Neuroscience; 2008 Mar; 152(1):223-33. PubMed ID: 18164554 [TBL] [Abstract][Full Text] [Related]
15. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686 [TBL] [Abstract][Full Text] [Related]
16. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease. Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931 [TBL] [Abstract][Full Text] [Related]
17. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. Rezai-Zadeh K; Shytle D; Sun N; Mori T; Hou H; Jeanniton D; Ehrhart J; Townsend K; Zeng J; Morgan D; Hardy J; Town T; Tan J J Neurosci; 2005 Sep; 25(38):8807-14. PubMed ID: 16177050 [TBL] [Abstract][Full Text] [Related]
18. Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease. Reznichenko L; Amit T; Zheng H; Avramovich-Tirosh Y; Youdim MB; Weinreb O; Mandel S J Neurochem; 2006 Apr; 97(2):527-36. PubMed ID: 16539659 [TBL] [Abstract][Full Text] [Related]
19. Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice. Hyde LA; Kazdoba TM; Grilli M; Lozza G; Brusa R; Zhang Q; Wong GT; McCool MF; Zhang L; Parker EM; Higgins GA Behav Brain Res; 2005 May; 160(2):344-55. PubMed ID: 15863231 [TBL] [Abstract][Full Text] [Related]
20. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease. Feng Z; Chang Y; Cheng Y; Zhang BL; Qu ZW; Qin C; Zhang JT J Pineal Res; 2004 Sep; 37(2):129-36. PubMed ID: 15298672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]